Can retinal photography cause phototoxicity?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 8, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Phototoxicity from Retinal Photography: Risk Assessment and Prevention

Yes, retinal photography can cause phototoxicity, particularly when combined with photosensitizing medications or with prolonged exposure times. 1

Mechanism and Risk Factors

Phototoxic maculopathy can occur from exposure to strong light sources used in ophthalmic procedures, including retinal photography. The risk increases with:

  • Photosensitizing medications: Tetracyclines, retinoids, amiodarone, hydrochlorothiazide, furosemide, allopurinol, and benzodiazepines significantly increase phototoxicity risk 1, 2
  • Exposure duration: Longer exposure times and multiple flashes increase risk 1, 3
  • Light intensity: More powerful light sources used in modern imaging equipment increase potential damage 3
  • Wavelength: Blue-violet light (425-445 nm) is particularly toxic to cone photoreceptors 4

Clinical Presentation

Patients with phototoxic maculopathy may present with:

  • Scotomas (blind spots)
  • Visual loss
  • Yellow-gray sub-retinal lesions visible on fundus examination
  • Hypofluorescent spots surrounded by hyperfluorescent window defects on fluorescein angiography 2

Prevention Strategies

To minimize the risk of phototoxicity during retinal photography:

  1. Screen for photosensitizing medications before retinal photography 1
  2. Minimize exposure time and number of flashes used during imaging 1
  3. Use appropriate filters to reduce harmful wavelengths
  4. Consider protective eyewear with UV filtering for patients at higher risk 1
  5. Shield uninvolved areas similar to recommendations for phototherapy (e.g., covering face if not being imaged) 5

Management of Suspected Phototoxicity

If phototoxicity is suspected following retinal photography:

  1. Perform OCT imaging to detect structural changes in the retina 1
  2. Document baseline findings including comprehensive OCT scan
  3. Conduct visual field testing if symptoms persist 1
  4. Schedule follow-up in 1-3 months to confirm resolution and repeat OCT 1

Prognosis

The prognosis for phototoxicity from retinal photography is generally favorable:

  • Complete visual recovery typically occurs within a few months
  • Even with visual recovery, subtle retinal pigment epithelial disturbances may persist but usually without functional impact 1, 2
  • Early detection and intervention before structural damage develops allows for the best outcomes 1

Special Considerations

  • Patients with pre-existing retinal conditions may have increased susceptibility to phototoxicity
  • The risk of permanent vision loss is significantly lower when initial OCT is normal 1
  • Persistence of symptoms beyond 3-4 months or development of OCT abnormalities requires close monitoring 1

Retinal phototoxicity from diagnostic imaging represents a balance between obtaining necessary clinical information and minimizing risk to the patient. With proper precautions and awareness of risk factors, the likelihood of significant phototoxic damage can be substantially reduced.

References

Guideline

Phototoxic Maculopathy Diagnosis and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Incidental retinal phototoxicity associated with ingestion of photosensitizing drugs.

Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie, 2001

Research

Retinal phototoxicity.

International ophthalmology clinics, 1999

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.